These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 20558846)

  • 1. Lack of uniform progression of endocardial scar in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and ventricular tachycardia.
    Riley MP; Zado E; Bala R; Callans DJ; Cooper J; Dixit S; Garcia F; Gerstenfeld EP; Hutchinson MD; Lin D; Patel V; Verdino R; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):332-8. PubMed ID: 20558846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Layered activation of epicardial scar in arrhythmogenic right ventricular dysplasia: possible substrate for confined epicardial circuits.
    Haqqani HM; Tschabrunn CM; Betensky BP; Lavi N; Tzou WS; Zado ES; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):796-803. PubMed ID: 22634228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
    Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy.
    Marchlinski FE; Zado E; Dixit S; Gerstenfeld E; Callans DJ; Hsia H; Lin D; Nayak H; Russo A; Pulliam W
    Circulation; 2004 Oct; 110(16):2293-8. PubMed ID: 15477406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Structural Changes in Arrhythmogenic Right Ventricular Cardiomyopathy With Recurrent Ventricular Tachycardia After Ablation: Insights From Repeat Electroanatomic Voltage Mapping.
    Briceño DF; Liang JJ; Shirai Y; Markman TM; Chahal A; Tschabrunn C; Zado E; Hyman MC; Kumareswaran R; Arkles JS; Santangeli P; Schaller RD; Supple GE; Frankel DS; Deo R; Riley MP; Nazarian S; Lin D; Epstein AE; Garcia FC; Dixit S; Callans DJ; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2020 Jan; 13(1):e007611. PubMed ID: 31922914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique.
    Berruezo A; Fernández-Armenta J; Mont L; Zeljko H; Andreu D; Herczku C; Boussy T; Tolosana JM; Arbelo E; Brugada J
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):111-21. PubMed ID: 22205683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia.
    Verma A; Kilicaslan F; Schweikert RA; Tomassoni G; Rossillo A; Marrouche NF; Ozduran V; Wazni OM; Elayi SC; Saenz LC; Minor S; Cummings JE; Burkhardt JD; Hao S; Beheiry S; Tchou PJ; Natale A
    Circulation; 2005 Jun; 111(24):3209-16. PubMed ID: 15956125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroanatomic mapping of the endocardium. Implication for catheter ablation of ventricular tachycardia.
    Wetzel U; Hindricks G; Dorszewski A; Schirdewahn P; Gerds-Li JH; Piorkowski C; Kobza R; Tanner H; Kottkamp H
    Herz; 2003 Nov; 28(7):583-90. PubMed ID: 14689118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VT Recurrence After Ablation: Incomplete Ablation or Disease Progression? A Multicentric European Study.
    Berte B; Sacher F; Venlet J; Andreu D; Mahida S; Aldhoon B; DE Potter T; Sarkozy A; Tavernier R; Andronache M; Deneke T; Kautzner J; Berruezo A; Cochet H; Zeppenfeld K; Jaïs P
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):80-7. PubMed ID: 26471955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy.
    Dukkipati SR; d'Avila A; Soejima K; Bala R; Inada K; Singh S; Stevenson WG; Marchlinski FE; Reddy VY
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):185-94. PubMed ID: 21270104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-contact mapping to guide catheter ablation of untolerated ventricular tachycardia.
    Della Bella P; Pappalardo A; Riva S; Tondo C; Fassini G; Trevisi N
    Eur Heart J; 2002 May; 23(9):742-52. PubMed ID: 11978001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced.
    Te Riele AS; James CA; Philips B; Rastegar N; Bhonsale A; Groeneweg JA; Murray B; Tichnell C; Judge DP; Van Der Heijden JF; Cramer MJ; Velthuis BK; Bluemke DA; Zimmerman SL; Kamel IR; Hauer RN; Calkins H; Tandri H
    J Cardiovasc Electrophysiol; 2013 Dec; 24(12):1311-20. PubMed ID: 23889974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; Jain R; Tandri H; Dong J; Eid SM; Prakasa K; Tichnell C; James C; Abraham T; Russell SD; Sinha S; Judge DP; Bluemke DA; Marine JE; Calkins H
    J Am Coll Cardiol; 2007 Jul; 50(5):432-40. PubMed ID: 17662396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of ripple mapping for identification of slow conduction channels during ventricular tachycardia ablation in the setting of arrhythmogenic right ventricular cardiomyopathy.
    Xie S; Kubala M; Liang JJ; Yang J; Desjardins B; Santangeli P; van der Geest RJ; Schaller R; Riley M; Supple G; Frankel DS; Callans D; Pac EZ; Marchlinski F; Nazarian S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):366-373. PubMed ID: 30575168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Basso C; Leoni L; Tokajuk B; Bauce B; Frigo G; Tarantini G; Napodano M; Turrini P; Ramondo A; Daliento L; Nava A; Buja G; Iliceto S; Thiene G
    Circulation; 2005 Jun; 111(23):3042-50. PubMed ID: 15939822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial voltage ratio in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Müssigbrodt A; Bertagnolli L; Efimova E; Kosiuk J; Dinov B; Bode K; Kircher S; Dagres N; Döring M; Richter S; Sommer P; Husser D; Bollmann A; Hindricks G; Arya A
    Herzschrittmacherther Elektrophysiol; 2017 Jun; 28(2):219-224. PubMed ID: 28536891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-Guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators.
    Dickfeld T; Tian J; Ahmad G; Jimenez A; Turgeman A; Kuk R; Peters M; Saliaris A; Saba M; Shorofsky S; Jeudy J
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):172-84. PubMed ID: 21270103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.